The approval makes Dupixent the first FDA-approved therapy for allergic fungal rhinosinusitis, supported by Phase III data showing significant improvements in sinus opacification, nasal symptoms, and ...

Aldeyra Therapeutics reported positive results from a Phase III study of Reproxalap, an eye drop drug for allergic conjunctivitis and dry eye disease that provides immediate relief to patients. The ...

A new study published in the journal of Contact Lens & Anterior Eye showed that the risk of keratoconus and corneal erosion is considerably higher in individuals with allergic ...

Please provide your email address to receive an email when new articles are posted on . Lirentelimab safely improved severe allergy conjunctivitis and concomitant atopic symptoms, according to a study ...

Please provide your email address to receive an email when new articles are posted on . Children who are more physically fit than their peers experience reduced risk for allergic conjunctivitis, ...

For patients aged 5 to 25 years, allergic conjunctivitis is associated with an increased risk for keratoconus and increased corneal diagnostic procedures, according to a study published in the ...

There are several OTC therapies available to combat allergic conjunctivitis. The topical ophthalmic H1 antihistamines have a more rapid onset of action than oral H1 antihistamines but require more ...

Vernal keratoconjunctivitis (VKC) is a chronic, bilateral, allergic condition primarily affecting children and young adults. It is a seasonal allergic inflammatory disease of the eye with episodes of ...

Oral second-generation antihistamines are considered first-line therapy for allergic rhinitis but are not indicated for nonallergic vasomotor rhinitis. 1 Intranasal antihistamines can also be ...